References1. Data on � le. AMO Development, LLC. CustomVue Procedure clinical trials submitted to the FDA; 2002, 2003, 2004 & 2005.

20/16 results delivered with excimer laser; clinical studies sent to the FDA via 930016 supplements 016, 017, 020 & 021.2. Donnenfeld E. Preservation of corneal innervation with femtosecond laser inverted sidecut � aps. Invest Opthalmol Vis Sci. 2010 51: E-Abstract 2855. 3. Knorz MC, Vossmerbaeumer U. Comparison of � ap adhesion strength using the AMADEUS microkeratome and the IntraLase iFS

femtosecond laser in rabbits. J Refract Surg. 2008;24(9):875-878.4. Greenberg K. WaveScan WaveFront System key to individualized LASIK treatment. Refractive Eyecare. April 2010.

© 2011 Abbott Medical Optics Inc. Advanced CustomVue, iFS, iLASIK, IntraLase, STAR S4 IR and WaveScan WaveFront are trademarks owned by or licensed to Abbott Laboratories, its subsidiaries or af� liates. Accutane is a registered trademark of Hoffmann-LaRoche Inc. Cordarone is a registered trademark of Sanofi-Synthelabo, Inc. 2011.12.06-RF4342

Scan this code or visit www.amo-ilasik.com/proven to learn how to bring proven technology, that’s good enough for NASA, to your patients.

iLASIK Technology:True Customization for ResultsBeyond 20/201

iLASIK Technology Helps You Take

More of Your Patients Beyond 20/201

The iLASIK Technology Suite is the exclusive combination of IntraLase and Advanced CustomVue Technologies — proven technologies for proven results.

References1. Data on � le. AMO Development, LLC. CustomVue Procedure clinical trials submitted to the FDA; 2002, 2003, 2004 & 2005.

20/16 results delivered with excimer laser; clinical studies sent to the FDA via 930016 supplements 016, 017, 020 & 021.2. Donnenfeld E. Preservation of corneal innervation with femtosecond laser inverted sidecut � aps. 2010 51: E-Abstract 2855. 3. Knorz MC, Vossmerbaeumer U. Comparison of � ap adhesion strength using the AMADEUS microkeratome and the IntraLase iFS

femtosecond laser in rabbits. 4. Greenberg K. WaveScan WaveFront System key to individualized LASIK treatment.

© 2011 Abbott Medical Optics Inc. Advanced CustomVue, iFS, iLASIK, IntraLase, STAR S4 IR and WaveScan WaveFront are trademarks owned by or licensed to Abbott Laboratories, its subsidiaries or af� liates. Hoffmann-LaRoche Inc. Cordarone is a registered trademark of Sanofi-Synthelabo, Inc. 2011.12.06-RF4342

Laser assisted in-situ keratomileusis (LASIK) can only be performed by a trained ophthalmologist and for speci� ed reduction or elimination of myopia, hyperopia, and astigmatism as indicated within the product labeling. For safety information, please see inside.

PROVENPROVENPROVENPROVENPROVEN

Over 20 Years of Innovation andMore Than 15 Million Procedures Worldwide

iLASIK Technology Is Proven To Deliver Truly Customized Laser Vision Correction

Expert Teams and Innovative Tools To Maximize Your Practice’s Success

Captain (Ret.) Steven C. Schallhorn, MD

The iLASIK Technology Suite is a comprehensive wavefront-guided laser vision correction system that allows the surgeon to fully customize every aspect of the refractive surgical procedure.

The iFS Advanced Femtosecond Laser features proven IntraLase Technology, giving surgeons greater control for maximum customization.

Promotes faster visual recovery and rapid healing2

Inverted bevel-in side cut up to 150° for optimal biomechanical stability3

Ability to create customized incisions for optimized tissue resection

iLASIK Technology achieves excellent outcomes with innovations like the iFS Advanced Femtosecond Laser and Advanced CustomVue Technology. The combination of these technologies makes a signi� cant difference in the quality and consistency of refractive surgery outcomes.

Surgeons are seeing:

Patients with 20/16 or better visual acuity1

Patients reporting excellent night vision1

An extensive range of patients they can treat

High levels of patient satisfaction with post-operative uncorrected vision, as compared to vision before the procedure with glasses or contact lenses1

iLASIK Technology is the proven industry leader. In fact, NASA astronauts and U.S. Aviators can have laser vision correction surgery today because of its exclusive, validated safety and precision performance.

Advanced CustomVue Technology measures and treats individualized imperfections of each eye.

The WaveScan WaveFront System creates an accurate, objective measurement of the patient’s entire optical system, including both higher- and lower-order aberrations4

The Star S4 IR Excimer Laser delivers precise levels of ablation accuracy essential to optimizing outcomes

Abbott Medical Optics Inc. is committed to ensuring the ongoing success of your practice, and our dedicated staff and programs extend well beyond our technology.

A best-in-class business development team

Invaluable clinical and technical support

Award-winning customer service

A wealth of practice and patient marketing tools

Specialized workshops for ongoing learning and best practice sharing

“We get exceptional outcomes and high patient satisfaction, and by using iLASIK Technology, we’ve been able to drive signi� cant growth in our practice.”

74% of low to moderate myopes achieved UCVA20/16 or better (six months post-op) 1

65% of high myopes achieved UCVA 20/16 or better (six months post-op) 1

Beyond 20/201

For more information and to contact an AMO representative, go to www.amo-ilasik.com or call 877-AMO-4LIFE.

“The insights, ideas andstrategies our BusinessDevelopment Manager brings arean invaluable asset to the growthof our practice.”

Kerry D. Solomon, MD

PROVENPROVEN

optimized tissue resection

PROVENiFS Technology

Advanced CustomVueTechnology

and best practice sharing

The IntraLase FS and iFS Laser Systems are ophthalmic surgical lasers indicated for use in patients undergoing surgery or treatment requiring the initial lamellar resection of the cornea. Contraindications may include corneal edema, glaucoma, and keratoconus. Risks and complications may include corneal pain, � ap tearing, and epithelial ingrowth. Patients are requested to consult with their eye care professional for a complete listing of contraindications and risks. U.S. Federal Law restricts this device to sale, distribution, and use by or on the order of a physician or other licensed eye care professional. Laser assisted in-situ keratomileusis (LASIK) can only be performed by a trained ophthalmologist and for speci� ed reduction or elimination of myopia, hyperopia, and astigmatism as indicated within the product labeling. Laser refractive surgery is contraindicated for patients: a) with collagen vascular, autoimmune, or immunode� ciency diseases; b) who are pregnant or nursing women; c) with signs of keratoconus or abnormal corneal topography; d) who are taking one or both of the following medications: Isotretinoin (Accutane) and Amiodarone hydrochloride (Cordarone). Potential side effects to laser refractive surgery may include glare, dry eye, as well as other visual anomalies. LASIK requires the use of a microkeratome that cuts a � ap on the surface of the cornea, potential side effects may include � ap related complications. Patients are requested to consult with their eye care professional and Patient Information Booklet regarding the potential risks and bene� ts for laser refractive surgery, results may vary for each individual patient. Restricted Device: U.S. Federal Law restricts this device to sale, distribution, and use by or on the order of a physician or other licensed eye care practitioner. U.S. Federal Law restricts the use of this device to professionals who have been trained in its calibration and operation and who have experience in the surgical treatment and management of refractive errors.